Table 2.
Studied variables in BSIs cases based on outcomes and use of the catheter in Non- ICU wards
| Variables | Outcome | Catheter | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Discharge (n=513) | Dead (n=92) | P* | Yes (111) | No (515) | P | |
| Age (year) | 54.27±21.95 | 62.55±21.06 | 0.001 | 56.45±21.47 | 55.22±21.97 | 0.605 |
| Hospitalisation length (day) | 26.94±23.65 | 25.47±18.32 | 0.573 | 30.22±27.26 | 26.07±21.97 | 0.164 |
| Duration between hospitalisation and incidence of BSIs (day) | 13.07±19.19 | 15.74±15.81 | 0.209 | 14.03±18.97 | 13.44±18.92 | 0.765 |
| Duration between inserting catheter and incidence of BSIs (day) | 27.22±62.00 | 21.00±40.68 | 0.728 | - | - | - |
| Duration between incidence of BSIs and discharging/death (day) | 13.87±12.19 | 9.73±11.61 | 0.003 | 17.13±18.16 | 12.52±10.59 | 0.018 |
| Sex | ||||||
| Male | 239 (46.6%) | 32 (34.8%) | 0.036 | 54 (19.2%) | 227 (80.8%) | 0.38 |
| Female | 274 (53.4%) | 60 (65.2%) | 57 (16.5%) | 288 (83.5%) | ||
| Year | ||||||
| 2017 | 60 (84.5%) | 11 (15.5%) | <0.001 | 73 | 12 | <0.001 |
| 2018 | 191 (82%) | 42 (18%) | 33 | 205 | ||
| 2019 | 150 (95.5%) | 7 (4.5%) | 5 | 153 | ||
| 2020 | 112 (77.8%) | 32 (22.2%) | 0 | 145 | ||
| Catheter | ||||||
| Central venous catheter | 49 (80.3%) | 12 (19.7%) | 0.019 | - | - | - |
| Peripheral venous catheter | 25 (100%) | 0 | ||||
| Arterial catheter | 2 (66.7%) | 1 (33.3%) | ||||
| Other | 6 (100%) | 0 | ||||
| Without catheter | 431 (84.5%) | 79 (15.5%) | ||||
| Organism | ||||||
| Acinetobacter | 98 (19.1%) | 27 (29.3%) | 0.13 | 14 (12.6%) | 113 (21.9%) | <0.001 |
| Staphylococcus epidermidis** | 168 (32.7%) | 20 (21.7%) | 40 (36.0%) | 152 (29.5%) | ||
| Enterobacter | 36 (7%) | 3 (3.3%) | 1 (0.9%) | 38 (7.4%) | ||
| Pseudomonas aeruginosa | 19 (3.7%) | 7 (7.6%) | 11 (9.9%) | 16 (3.1%) | ||
| Candida | 20 (3.9%) | 5 (5.4%) | 5 (4.5%) | 21 (4.1%) | ||
| Enterococcus | 21 (4.1%) | 6 (6.5%) | 7 (6.3%) | 22 (4.3%) | ||
| Klebsiella | 59 (11.5%) | 9 (9.8%) | 6 (5.4%) | 65 (12.6%) | ||
| Staphylococcus aureus | 45 (8.8%) | 8 (8.7%) | 12 (10.8%) | 45 (8.7%) | ||
| E. coli | 33 (6.4%) | 4 (4.3%) | 8 (7.2%) | 30 (5.8%) | ||
| Other | 14 (2.7%) | 3 (3.3%) | 7 (6.3%) | 13 (2.5%) | ||
| Ward | ||||||
| Neurology | 47 (9.2%) | 13 (14.1%) | 0.032 | 10 (9%) | 52 (10.1%) | 0.002 |
| Pediatrics | 13 (2.5%) | 0 | 8 (7.2%) | 5 (1.0%) | ||
| Surgery | 160 (31.2%) | 29 (31.5%) | 30 (27.0%) | 166 (32.2%) | ||
| Internal medicine | 269 (52.4%) | 44 (47.8%) | 58 (52.3%) | 266 (51.7%) | ||
| Obstetrics and Gynecology | 13 (2.5%) | 0 | 1 (0.9%) | 12 (2.3%) | ||
| Infectious | 11 (2.1%) | 6 (6.5%) | 4 (3.6%) | 2.7%) | ||
*P<0.05 was considered significant. **Confirmed with two sample